vimarsana.com

Latest Breaking News On - Rakesh navuluri - Page 1 : vimarsana.com

Instylla announces enrollment of initial patient in the prospective multicenter HALT Study

The HALT Study at MemorialCare Long Beach Medical Center is intended for the treatment of peripheral arterial bleeds.

United statesSuvranu ganguliDavid tahourLos angeles metroDavid caoQian yuTimothy jarrettEric john gandrasJeffrey leefRaymond lareauOsman ahmedSteven zanganAmar sawhneyRakesh navuluriAmanda zhangBrian funaki

Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter HALT Study

/PRNewswire/ Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the.

United statesSuvranu ganguliDavid tahourDavid caoQian yuTimothy jarrettEric john gandrasJeffrey leefRaymond lareauSteven zanganAmar sawhneyRakesh navuluriAmanda zhangBrian funakiInstylla incAmerican association for the surgery of trauma

vimarsana © 2020. All Rights Reserved.